![](/img/cover-not-exists.png)
Late Toxicity and Quality of Life from GETUG-AFU 22 Study: A Multicenter Randomized Phase II Trial Comparing Radiotherapy +/- 6 Months of Degarelix as a Salvage Treatment for Patients with Detectable PSA after Radical Prostatectomy
Latorzeff, I., Guerif, S., Fraisse, J., Meyer, E., Supiot, S., Lagneau, E., Deniaud-Alexandre, E., Ronchin, P., Benyoucef, A., Cartier, L., Hamidou, H., Hasbini, A., Crehange, G., Pommier, P., Magne,Volume:
105
Language:
english
Journal:
International Journal of Radiation Oncology*Biology*Physics
DOI:
10.1016/j.ijrobp.2019.06.123
Date:
September, 2019
File:
PDF, 191 KB
english, 2019